Molecular mechanisms of CD8+T cell-mediated delayed hypersensitivity: Implications for allergies, asthma, and autoimmunity

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 2 II, 1999, Pages 192-199

  Kalish, Richard S ^a   Askenase, Philip W ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allergic contact dermatitis; Asthma; CD8+; Delayed hypersensitivity; Drug eruptions; T lymphocytes

Indexed keywords

CD8 ANTIGEN; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN;

ALLERGY; ANTIGEN RECOGNITION; ASTHMA; AUTOIMMUNITY; DELAYED HYPERSENSITIVITY; HUMAN; IMMUNOPATHOGENESIS; LYMPHOCYTIC INFILTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION;

ANIMALS; ASTHMA; AUTOIMMUNE DISEASES; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; HYPERSENSITIVITY; HYPERSENSITIVITY, DELAYED; IMMUNITY, CELLULAR;

EID: 0033012134     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(99)70489-6     Document Type: Article

References (100)

1. Berke G. The CTL's kiss of death. Cell 1995;81:9-12.
2. Hahn S, Gehri R, Erb P. Mechanism and biological significance of CD4-mediated cytotoxicity. Immunol Rev 1995;146:57-79.
3. Shimonkevitz R, Kappler J, Marrack P, Grey H. Antigen recognition by H-2 restricted T cells I. Cell-free antigen processing. J Exp Med 1983;158:303-16.
4. Kurt-Jones EA, Beller DI, Mizel SB, Unanue ER. Identification of a membrane-associated interleukin 1 in macrophages. Proc Natl Acad Sci USA 1985;82:1204-8.
5. Germain RN. The ins and outs of antigen processing and presentation. Nature 1986;322:687-9.
6. d. Science 1992;256:1817-20.
7. Tapper H, Sundler R. Role of lysosomal and cytosolic pH in the regulation of macrophage lysosomal enzyme secretion. Biochem J 1990;272:407-14.
8. Ziegler HK, Unanue ER. Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci U S A 1982;79:175-8.
9. Rodriguez GM, Diment S. Role of cathepsin D in antigen presentation of ovalbumin. J Immunol 1992;149:2894-8.
10. Teyton L, O'Sullivan D, Dickson PW, Lotteau V, Sette A, Fink P, et al. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature 1990;348:39-44.
11. Bodmer H, Viville S, Benoist C, Mathis D. Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain. Science 1994;263:1284-6.
12. Neefhes JJ, Ploegh HL. Intracellular transport of MHC class II molecules. Immunol Today 1992;13:179-84.
13. Cresswell P. Questions of presentation. Nature 1990;343:593-4.
14. Sweetser MT, Morrison LA, Braciale VL, Braciale TJ. Recognition of pre-processed endogenous antigen by class I but not class II MHC-restricted T cells. Nature 1989;342:180-2.
15. Michalek MT, Grant EP, Gramm C, Goldberg AL, Rock KL. A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation. Nature (London) 1993;363:552-4.
16. Spataro V, Norbury C, Harris AL. The ubiquitin-proteasome pathway in cancer. Br J Cancer 1998;77:448-55.
17. Cox JH, Yewdell JW, Eisenlohr LC, Johnson PR, Bennink JR. Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. Science 1990;247:715-8.
18. Momburg F, Hammerling GJ. Generation and TAP-mediated transport of peptides for major histocompatibility complex class I molecules. Adv Immunol 1998;68:191-256.
19. Nuchtern JG, Bonifacino JS, Biddison WE, Klausner RD. Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation. Nature 1989;339:223-5.
20. Reinherz EL, Kung PC, Goldstein G, Schlossman SE. Further characterization of the human inducer T cell subset defined by monoclonal antibody. J Immunol 1979;123:2894-6.
21. Cher DJ, Mosman TR. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J Immunol 1987;138:3688-94.
22. Su HC, Cousens LP, Fast LD, Slifka MK, Bungiro RD, Ahmed R. CD4+ and CD8+ T cell interactions in IFN-γ and IL-4 responses to viral infections: requirements for IL-2. J Immunol 1998;160:5007-17.
23. Jin Y, Shih W, Berkower I. Human T cell response to the surface antigen of hepatitis B virus (HBsAg): endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen. J Exp Med 1988;168:293-306.
24. Liu T, Chambers B, Diehl AD, Van Kaer L, Jondal M, Ljunggren HG. TAP peptide transporter-independent presentation of heat-killed Sendai virus antigen on MHC class I molecules by splenic antigen-presenting cells. J Immunol 1997;159:5364-71.
25. Nuchtern JG, Biddison WE, Klausner RD. Class II MHC molecules can use the endogenous pathway of antigen presentation. Nature 1990;343:74-6.
26. Jaraquemada D, Marti M, Long EO. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells. J Exp Med 1990;172:947-54.
27. Street NE, Mosmann TR. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J 1991;5:171-7.
28. Coffman RL, Ohara J, Bond MW, Carty J, Zlotnik A, Paul WE. B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J Immunol 1986;136:4538-41.
29. Griffiths CEM, Voorhees JJ, Nickoloff BJ. Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol 1989;20:617-29.
30. Kapsenberg ML, Wierenga EA, Stiekema FEM, Tiggelman AMBC, Bos JD. Th1 lymphokine production profiles of nickel-specific CD4+ T-lymphocyte clones from nickel contact allergic and non-allergic individuals. J Invest Dermatol 1992;98:59-63.
31. Kalish RS, Morimoto C. Quantitation and cloning of human urushiol specific peripheral blood T-cells: isolation of urushiol specific suppressor T-cells. J Invest Dermatol 1989;92:46-52.
32. Xu H, DiLulio NA, Fairchild RL. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon γ-producing (Tel) effector CD8+ T cells and interleukin (IL) 4/11-10 producing (TH2) negative regulatory CD4+ T cells. J Exp Med 1996;183:1-12.
33. Noble A, Macary PA, Kemeny M. INF-γ and IL-4 regulate the growth and differentiation of CD8+ T cells into subpopulations with distinct cytokine profiles.: Immunol 1995;155:2928-37.
34. Kalish RS, Johnson KL. Enrichment and function of urushiol (poison ivy) specific T-lymphocytes in lesions of allergic contact dermatitis to urushiol. J Immunol 1990;145:3706-13.
35. Bour H, Peyron E, Gaucherand M, Garrigue JL, Desvignes C, Kaiserlian D, et al. Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur J Immunol 1995;25:3006-10.
36. Bouloc A, Cavani A, Katz SI. Contact hypersensitivity in MHC class II-deficient mice depends on CD8 T lymphocytes primed by immunostimulating Langerhans cells. J Invest Dermatol 1998; 111:44-9.
37. Shultz L, Bailey DW. Genetic control of contact sensitivity in mice: effect of H-2 and non H-2 loci. Immunogenetics 1975;1:570-83.
38. Sunday ME, Weinberger JZ, Benacerral B, Dorf ME. Hapten-specific T cell responses to 4-hydroxyl-3-nitrophenyl acetyl IV. specificity of cutaneous sensitivity responses. J Immunol 1980;125:1601-5.
39. Smith KJ, Skelton HG, Nelson A, Wagner KF, Hackley BE Jr. Preservation of allergic contact dermatitis to poison ivy (urushiol) in late HIV disease. The implications and relevance to immunotherapy with contact allergens. Dermatology 1997;195:145-9.
40. Dupuis G, Benezra C, editors. Chemically reactive functions in haptens and in proteins. In: Allergic contact dermatitis to simple chemicals a molecular approach. New York: Marcel Dekker Inc; 1982. p. 47-84.
41. Romagnoli P, Sinigaglia F. Selective interaction of Ni with an MHC-bound peptide. EMBO J 1991;10:1303-6.
42. Baer H. Chemistry and immunology of poisonous Anacardiaceae. Clin Dermatol 1986;4:152-9.
43. Byck JS, Dawson CR. Assay of protein-quinone coupling involving compounds structurally related to the active principle of poison ivy. Anal Biochem 1968;25:123-35.
44. Schmidt RJ, Khan L, Chung LY. Are free radicals and not quinones the haptenic species derived from urushiol and other contact allergenic monoand dihydric alkylbenzenes? The significance of NADH, glutathione, and redox cycling in the skin. Arch Dermatol Res 1990;282:56-64.
45. Ma J, Wand JH, Sy MS, Gou YJ, Hauser C, Bigby M. Trinitrophenol reactive T-cell hybridomas recognize antigens that require antigen processing. J Invest Dermatol 1994;103:42-8.
46. Kalish RS, Wood JA, LaPorte A. Processing of urushiol (poison ivy) hapten by both endogenous and exogenous pathways for presentation to human T-cells. J Clin Invest 1994;93:2039-47.
47. Sinigaglia F, Scheidegger D, Garotta G, Scheper R, Pletscher M, Lanzavecchia A. Isolation and characterization of Ni-specific T-cell clones from patients with Ni-contact dermatitis. J Immunol 1985;135:3929-32.
48. Löfström A, Wigzell H. Antigen specific human T-cell lines specific for cobalt chloride. Acta Derm Venereol 1986;60:200-6.
49. Moulon C, Wild D, Dormoy A, Weltzien HU. MHC-dependent and -independent activation of human nickel-specific CD8+ cytotoxic T cells from allergic donors. J Invest Dermatol 1998;111:360-6.
50. Cavani A, Mei D, Guerra E, Corinti S, Giani M, Pirrotta L, et al. Patients with allergic contact dermatitis to nickel and nonallergic individuals display different nickel-specific T cell responses. Evidence for the presence of effector CD8+ and regulatory CD4+ T cells. J Invest Dermatol 1998;111:621-8.
51. Gocinski BL, Tigelaar RE. Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J Immunol 1990;144:4121-8.
52. Dai WJ, Bartens W, Kohler G, Hufnagel M, Kopf M, Brombacher F. Impaired macrophage listericidal and cytokine activities are responsible for the rapid death of Listeria monocytogenes-infected IFN-γ receptor-deficient mice. J Immunol 1997;158:5297-304.
53. Munk ME, Emoto M. Functions of T-cell subsets and cytokines in mycobacterial infections. Eur Respir J Suppl 1995;20:668s-75s.
54. Jiang X, Gregory SH, Wing EJ. Immune CD8+ T lymphocytes lyse Listeria monocytogenes-infected hepatocytes by a classical MHC class I-restricted mechanism. J Immunol 1997;158:287-93.
55. Kagi D, Ledermann B, Burki K, Zinkernagel RM, Hengartner H. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Ann Rev Immunol 1996;14:207-32.
56. Doherty PC. Cytotoxic T cell effector and memory function in viral immunity. Curr Top Microbiol Immunol 1996;206:1-14.
57. Sterkes G, Henin Y, Lepage V, Fradelizzi D, Hannoun C, Levy JP. Influenza A hemagglutinin-specific T cell clones strictly restricted by HLA-DR1 or HLA-DR7 molecules. Eur J Immunol 1984;14:125-32.
58. Mills KHG. Processing of viral antigens and presentation to class II-restricted T cells. Immunol Today 1986;7:260-3.
59. Tonnesen MG, Harrist TJ, Wintroub BU, Mihm MC, Soter NA. Erythema multiforme: microvascular damage and infiltration of lymphocytes and basophils. J Invest Dermatol 1983;80:282-6.
60. Ferrara JLM, Deeg HJ. Graft-versus-host disease. N Engl J Med 1991;324:667-74.
61. Margolis RJ, Tonnesen MG, Harrist TJ, Bhan AK, Wintroub BU, Mihm MC, et al. Lymphocyte subsets and Langerhans cells/indeterminate cells in erythema multiforme. J Invest Dermatol 1983;81:403-6.
62. Spielberg SP. In vitro assessment of pharmacogenetic susceptibility to toxic drug metabolites in humans. Fed Proc 1984;43:2308-13.
63. Khan IU, Bickers DR, Haqqi TM, Mukhtar H. Induction of CYP1A1 mRNA in rat epidermis and cultured human epidermal keratinocytes by benz[a]anthracene and b-naphthoflavone. Drug Metab Dispos 1992;20:620-4.
64. Cribb AE, Spielberg SP. Sulfamethoxazole is metabolized to the hydroxylamine in humans. Clin Pharmacol Ther 1992;51:522-6.
65. Claesen M, Moustafa MAA, Adline J, Vandervorst D, Poupaert JH. Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of phenytoin to 5-(4-hydroxyphenyl)-5-phenylhydantoin in the rat and man. Drug Metab Dispos 1982;10:667-71.
66. Cribb AE, Miller M, Tesoro A, Spielberg SP. Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs. Mol Pharmacol 1990;38:744-51.
67. Rieder MJ, Uetrecht J, Shear NH, Cannon M, Miller M, Spielberg SP Diagnosis of sulfonamide hypersensitivity reactions by in vitro "rechallenge" with hydroxylamine metabolites. Ann Intern Med 1989;110:286-9.
68. Pichler WJ, Zanni M, von Greyerz S, Schnyder B, Mauri-Hellweg D, Wendland T. High IL-5 production by human drug-specific T cell clones. Int Arch Allergy Immunology 1997;113:177-80.
69. Schnyder B, Mauri-Hellweg D, Zanni M, Bettens F, Pichler WJ. Direct, MHC-dependent presentation of the drug sulfamethoxazole to human a/b T cell clones. J Clin Invest 1997;100:136-41.
70. Zanni MP, Schnyder B, von Greyerz S, Pichler WJ. Involvement of T cells in drug-induced allergies. Trends Pharmacol Sci 1998;19:308-10.
71. Kalish RS, LaPorte A, Wood JA, Johnson KL. Sulfonamide reactive T-lymphocytes detected at very low frequency in the peripheral blood of patients with drug eruptions. J Allergy Clin Immunol 1994;94:465-72.
72. Hertl M, Bohlen H, Jugert F, Boecker C, Knaup R, Merk HF. Predominance of epidermal CD8+ T lymphocytes in bullous cutaneous reactions caused by β-lactam antibiotics. J Invest Dermatol 1993;101:794-9.
73. Hertl M, Geisel J, Merk HF. Selective generation of CD8+ T-cell clones from the peripheral blood of patients with cutaneous reactions to β-lactam antibiotics. Br J Dermatol 1993;128:619-26.
74. Padovan E, Bauer T, Tongio MM, Kalbacher H, Weltzien HU. Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy. Eur J Immunol 1997;27:1303-7.
75. Gordin FM, Simon GL, Wofsy CB, Mills J. Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immune deficiency syndrome. Ann Intern Med 1984;100:495-9.
76. O'Hehir RE, Eckels DD, Frew AJ, Kay AB, Lamb JR. MHC class II restriction specificity of cloned human T lymphocytes reactive with Dermatophagoides farinae (house dust mite). Immunology 1988;64:627-31.
77. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, et al. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-γ. J Allergy Clin Immunology 1996;97:1356-65.
78. Ying S, Humbert M, Barkans J, Corrigan CJ, Pfister R, Menz G, et al. Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1997;158:3539-44.
79. Stanciu LA, Shute J, Promwong C, Holgate ST, Djukanovic R. Increased levels of IL-4 in CD8+ T cells in atopic asthma. J Allergy Clin Immunol 1997;100:373-8.
80. Yurovsky VV, Weersink EJ, Meltzer SS, Moore WC, Postma DS, Bleecker ER, et al. T-cell repertoire in the blood and lungs of atopic asthmatics before and after ragweed challenge. Am J Respir Cell Mol Biol 1998;18:370-83.
81. Wahlstrom J, Dahlen B, Ihre E, Wigzell H, Grunewald J, Eklund A. Selective CD8+ T cells accumulate in the lungs of patients with allergic asthma after allergen bronchoprovocation. Clin Exp Immunol 1998;112:1-9.
82. Park HS, Nahm DH. Prognostic factors for toluene diisocyanate-induced occupational asthma after removal from exposure. Clin Exp Allergy 1997;27:1145-50.
83. Maestrelli P, Del Prete GF, Carli MD, D'Elios MM, Saetta M, Di Stefano A, et al. CD8 T-cell clones producing interleukin-5 and interferon-γ in bronchial mucosa of patients with asthma induced by toluene diisocyanate. Scand J Work Environ Health 1994;20:376-81.
84. Landau LI. Respiratory infections and wheezing in children. Curr Opin Pediatr 1996;8:3-5.
85. Coyle AJ, Bertrand C, Tsuyuki S, Pircher H, Walti S, Le Gros G, et al. IL-4 differentiates naive CD8+ T cells to a "Th2-like" phenotype: a link between viral infections and bronchial asthma. Ann NY Acad Sci 1996;796:97-103.
86. Coyle AJ, Erard F, Bertrand C, Walti S, Pircher H, Le Gros G. Virus-specific CD8+ cells can switch to interleukin 5 production and induce airway eosinophilia. J Exp Med 1995;181:1229-33.
87. Anett FC. HLA and the spondyloarthropathies. In: Calin A, editor. Spondyloarthropathies. New York: Grune and Stratton; 1984. p. 297-322.
88. Lehner T, Welsh KI, Batchelor JR. The relationship of HLA-B and DR phenotypes to Behcet's syndrome, recurrent oral ulceration and the class of immune complexes. Immunology 1982;47:581-7.
89. Thomson G. HLA disease associations: models for the study of complex human genetic disorders. Crit Rev Clin Lab Sci 1995;32:183-219.
90. Hohler T, Weinmann A, Schneider PM, Rittner C, Schopf RE, Knop J, et al. TAP-polymorphisms in juvenile onset psoriasis and psoriatic arthritis. Hum Immunol 1996;51:49-54.
91. Ridgway WM, Fathman CG. The association of MHC with autoimmune diseases: understanding the pathogenesis of autoimmune diabetes. Clin Immunol Immunopathol 1998;86:3-10.
92. Reveille JD. The genetic contribution to the pathogenesis of rheumatoid arthritis. Curr Opin Rheumatol 1998;10:187-200.
93. Penzotti JE, Nepom GT, Lybrand TP. Use of T cell receptor/HLA-DRB1 *04 molecular modeling to predict site-specific interactions for the DR shared epitope associated with rheumatoid arthritis. Arthritis Rheum 1997;40:1316-26.
94. Wang B, Gonzalez A, Benoist C, Mathis D. The role of CD8+ T cells in the initiation of insulin-dependent diabetes mellitus. Eur J Immunol 1996;26:1762-9.
95. Kurts C, Carbone FR, Barnden M, Blanas E, Allison J, Heath WR, et al. CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med 1997;186:2057-62.
96. Suarez-Pinzon W, Rajotte RV, Mosmann TR, Rabinovitch A. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-γ during β-cell destruction. Diabetes 1996;45:1350-7.
97. Hehmke B, Michaelis D, Gens E, Laube F, Kohnert KD. Aberrant activation of CD8+ T-cell and CD8+ T-cell subsets in patients with newly diagnosed IDDM. Diabetes 1995;44:1414-9.
98. Peakman M, Leslie RD, Alviggi L, Hawa M, Vergani D. Persistent activation of CD8+ T-cells characterizes prediabetic twins. Diabetes Care 1996;19:1177-84.
99. Tang H, Braley-Mullen H. Intravenous administration of deaggregated mouse thyroglobulin suppresses induction of experimental autoimmune thyroiditis and expression of both Th1 and Th2 cytokines. Int Immunol 1997;9:679-87.
100. Sugihara S, Fujiwara H, Niimi H, Shearer GM. Self-thyroid epithelialcell (TEC)-reactive CD8+ T cell lines/clones derived from autoimmune thyroiditis lesions. They recognize self-thyroid antigens directly on TEC to exhibit T helper cell 1-type lymphokine production and cytotoxicity against TEC. J Immunol 1995;155:1619-28.